January 21, 2014

Global Medicines Program participates in key conference in Accra, Ghana, November 4-5, 2010

Andy Stergachis presented at a podium session at the International Society of Pharmacovigilance (ISoP) 10th Annual Meeting, in Accra, Ghana on November 5, 2010. His topic was “Application of Pharmacovigilance Methods to Assessing the Safety of Antimalarials and Antiretroviral Medicines.” This is the first time that the ISoP Annual Meeting was held in a western African country. While in Accra, he also participated in a stakeholders meeting to review the WHO-Global Fund Pharmacovigilance Strategy Minimum Requirements and Pharmacovigilance Toolkits. The entire ISoP conference program can be accessed here.

Presentations at the Session on Safety of Medicines for HIV, TB, Malaria
Chairpersons: Jing Bao, US and Alexander Dodoo, Ghana

Pharmacovigilance and UNITAID – The Importance of Safety Monitoring to Funders of Medicines for Priority Disease Conditions
Lorenzo Llewellyn Witherspoon, Head of Procurement, UNITAID, Geneva, Switzerland

Assessment of Global Reporting of Adverse Drug Reactions for Antimalarials, Including Artemisinin-based Combination Therapies (ACTs), to the WHO Programme for International Drug Monitoring
Paul Lalvani, RaPID Pharmacovigilance Program, Edgewater, US

Pharmacovigilance for Tuberculosis Does Not Feature Prominently in Grant Applications to the Global Fund to Fight AIDS, Tuberculosis and Malaria
Alexander Dodoo, University of Ghana Medical School, Ghana

Is Artesunate-Amodiaquine Associated with More Adverse Drug Events Compared with the Other Anti-malarial Therapies?
Edmund Tetteh Nartey, Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, Accra, Ghana

Application of Pharmacovigilance Methods to Assessing the Safety of Antimalarials and ARVs
Andy Stergachis, Global Medicines Program, University of Washington, USA